Proteasome Inhibition in Multiple Myeloma

Speaker

Asher Chanan-Khan, M.D.

Date

September 27, 2010, 12:00 pm–1:00 pm

Location

KCBD Room 1103
University of Chicago

Description

HEMO-CO Proteasome Inhibition in Multiple Myeloma

Submitting Unit
Hematology/Oncology, Section of, Department of Medicine Type of Event
Conference
Date of Event
Monday, September 27 2010 Start Time
12:00 PM End Time
01:00 PM Building
Knapp Center for Biomedical Discovery Room
1103

Name of Series, Lectureship, Ceremony
Weekly Monday Conference

Title of talk or presentation
Proteasome Inhibition in Multiple Myeloma

Speaker’s Name and Degrees
Asher Chanan-Khan, M.D.

Speaker’s Institutional Affiliation
Roswell Park Cancer Institute

Description
THE UNIVERSITY OF CHICAGO
SECTION OF HEMATOLOGY/ONCOLOGY
WEEKLY MONDAY CONFERENCE

Monday, September 27, 2010
12:00 - 1:00 P.M.


Location: KCBD Auditorium (Rm 1103) on the 1st Floor (just right of the café)


“Proteasome Inhibition in Multiple Myeloma”

By:

Asher Chanan-Khan, M.D.
Associate Professor of Oncology
Roswell Park Cancer Institute


Learning Objectives: 1) Role of Protease Inhibitors in Multiple Myeloma; 2) Mechanism of Resistance to Protease Inhibitor; and 3) Novel Strategies to Target Resistance to Protease Inhibitors in Myeloma.

The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians and designates this activity for a maximum of 1 hour in category 1 credit toward the AMA Physician’s Recognition Award. Each physician should claim only those hours of credit he/she actually spent in the educational activity.
9/22/2010 12:50:21 PM smec


CME Credit
Yes

Contact Name
Susan Cadle

Contact Email
.(JavaScript must be enabled to view this email address)

Contact Phone
2-9864

 

Latest News

IGSB Fellow Yoav Gilad heads study on how social stress changes immune system gene expression in primates

“We were able to use gene expression to classify individuals based on their rank,” said Yoav Gilad, PhD, associate professor of human genetics at the University of Chicago Biological Sciences and senior author of the study in PNAS. “Demonstrating these very plastic and temporal changes was novel and quite interesting.” Press Release

UChicago scientists find untapped potential in the “microbiome” of bacteria inside the human body

While microbiologists were classically limited to studying only bacterial species they could get to grow in a laboratory dish, the new method of metagenomics has allowed ecologists to discover thousands of new species in a single scoop of soil or teaspoon of seawater. Now that technology is being applied by University of Chicago Medicine researchers, in collaboration with Argonne National Laboratory, to the ecosystem of the human gut.Press Release

IGSB Senior Fellow Janet Rowley wins the 2012 Japan Prize for Healthcare and Medical Technology

Janet Davison Rowley, MD, the Blum-Riese Distinguished Service Professor of Medicine, Molecular Genetics & Cell Biology and Human Genetics at the University of Chicago, will share the 2012 Japan Prize for Healthcare and Medical Technology with Brian J. Druker, MD, from the Oregon Health and Science University, and Nicholas B. Lydon, PhD, formerly with Novartis. They were chosen for their roles in the development of the first precisely targeted anti-cancer drug, called imatinib (Gleevec®). Press Release

IGSB Fellow Habibul Ahsan receives named professorship

Habibul Ahsan, MD, MMedSc, professor in the departments of health studies, human genetics and medicine, director of the Center for Cancer Epidemiology and Prevention at the University of Chicago Medical Center and associate director of the University of Chicago Comprehensive Cancer Center, has been named a Louis Block Professor. Press Release

Top Japanese Scientist leaving government post to move to the University of Chicago Medical Center

“Dr. Nakamura has made major contributions to modern genetics and genomics,” said Kenneth Polonsky, MD, Dean of the Biological Sciences Division and the Pritzker School of Medicine at the University of Chicago. “We are extremely gratified by his interest in continuing his illustrious career at the University of Chicago.”  Press Release

IGSB Core Faculty Robert Grossman appointed Chief Research Informatics Officer of the Division of the Biological Sciences

Robert Grossman, PhD, assumed the role of chief research informatics officer and is currently overseeing a research group focused on bioinformatics, data mining, data intensive computing and related areas. Press Release

Subscribe to RSS Feed